A Prospective, Observational Drug Utilization Study of Stribild in Adults with HIV-1 Infection

Trial Profile

A Prospective, Observational Drug Utilization Study of Stribild in Adults with HIV-1 Infection

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Jun 2016

At a glance

  • Drugs Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 14 Jun 2016 Planned End Date changed from 30 Jun 2016 to 30 Sep 2016.
    • 13 Jun 2016 Planned End Date changed from 30 Nov 2015 to 30 Jun 2016.
    • 18 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top